High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.

This publication has 58 references indexed in Scilit:

• Cholesterol‐lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes – CORALL study
  Journal of Internal Medicine, 2005
• Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells
  Journal of the American Society of Nephrology, 2004
• Clinical Trials and Lipid Guidelines for Type II Diabetes
  The Journal of Clinical Pharmacology, 2004
• Clinical Trials: Evidence and Unanswered Questions – Hyperlipidaemia
  Cerebrovascular Diseases, 2003
• Effects of statins on the vasculature: implications for aggressive lipid management in the cardiovascular metabolic syndrome
  The American Journal of Cardiology, 2003
• Reduction of Serum LDL-C Levels
  American Journal of Cardiovascular Drugs, 2003
• Lipid disorders in patients with type 2 diabetes
  Postgraduate Medicine, 2001
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Predictors of Stroke in Middle-Aged Patients With Non–Insulin-Dependent Diabetes
  Stroke, 1996
• Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program.
  Stroke, 1994